Abdominal obesity and metabolic syndrome
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome is associated with abdominal obesity, blood lipid disorders, inflammation, insulin resistance or full-blown diabetes, and increased risk of developing cardiovascular disease. Proposed criteria for identifying patients with metabolic syndrome have contributed greatly to preventive medicine, but the value of metabolic syndrome as a scientific concept remains controversial. The presence of metabolic syndrome alone cannot predict global cardiovascular disease risk. But abdominal obesity - the most prevalent manifestation of metabolic syndrome - is a marker of 'dysfunctional adipose tissue', and is of central importance in clinical diagnosis. Better risk assessment algorithms are needed to quantify diabetes and cardiovascular disease risk on a global scale.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is strongly linked to visceral fat accumulation around abdominal organs, disrupting normal endocrine functions more than subcutaneous fat (Dam et al., 2016; Després & Lemieux, 2006).”
From Long-term cardiometabolic effects of early institutionalization and foster care: Evidence from the Bucharest Early Intervention Project (2026) · cites this paper as Després & Lemieux, 2006
In the citing paper
“Alarmingly, obesity is known to pose a more substantial health hazard than the other CMD risks [19,20,21].”
In the citing paper
“Most tests of Fe status, however, are affected in response to subclinical inflammation and infections (690 -692) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [691]
In the citing paper
“The results of the present study contradict the prevailing dogma that VAT has deleterious metabolic effects (5,6).”
From Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity (2009) · cites this paper as [6]
In the citing paper
“The metabolic syndrome is a cluster of coronary heart disease risk factors-central obesity, hypertension, dyslipidemia, and glucose intolerance-that share an association with insulin resistance, which appears to be the primary underlying pathophysiologic disturbance (1).”
From Eating Meals Irregularly: A Novel Environmental Risk Factor for the Metabolic Syndrome (2008) · cites this paper as [1]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“In obesity, there is evidence of macrophage infiltration in adipose tissu”
BackgroundPrediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · cited 1×
“It has also been argued that current risk-assessment algorithms such as the Framingham Heart Study calculator of coronary heart disease (CHD) ris”
MethodThe metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Research works printed but not linked: 3
- Lemieux, I. et al. Contribution of interleukin-6 and tumor necrosis factor-alpha to the elevated C-reactive protein levels found in abdominally obese men. Obes. Res. 9, 66S (2001).
- Beckley, E. T. New ADA initiative moves beyond 'metabolic syndrome'. 'Cardiometabolic risk' proposed as umbrella term for diabetes risk factors. DOC News 3, 1–3 (2006).
- Després, J. P. From CVD risk to cardiometabolic risk. Presented at the Symposium of the International Chair on Cardiometabolic Risk. XIV International Symposium on Atherosclerosis (Rome, 18–22 June 2006).
Cited by
Items 801–900 of 1,035
Assmann, G., Schulte, H., & Seedorf, U. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.29 · Cited by 70
Kim, J. J. Y., Tan, Y., Xiao, L., Sun, Y.-L., & Qu, X. (2013) · BioMed Research International · doi:10.1155/2013/920128 · Cited by 70
“Metabolic syndrome has become a significant public health problem, affecting millions of people all over the world [1].”
BackgroundCheung, B. M. Y., Wat, N. M. S., Tam, S., Thomas, G. N., Leung, G. M., Cheng, C. H., Woo, J., Janus, E. D., Lau, C. P., Lam, T. H., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03110.x · Cited by 70
Ruilope, L. M., Després, J., Scheen, A. J., Pi‐Sunyer, X., Mancia, G., Zanchetti, A., & Gaal, L. V. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f2d625 · Cited by 74
Self-citationIs overweight an issue in phenylketonuria?
Rocha, J. C., MacDonald, A., & Trefz, F. K. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.08.012 · Cited by 70
“While in the general population the long term consequences of overweight and obesity are well described [2], studies are limited in PKU [1].”
Backgroundvan Wijk, J. P. H., & Cabezas, M. C. (2012) · International Journal of Vascular Medicine · doi:10.1155/2012/201027 · Cited by 68
“The MS is closely linked abdominal obesity [38], but absolute or partial lack of body fat may result in a similar metabolic risk profile [39–41].”
BackgroundEffect of the early-life nutritional environment on fecundity and fertility of mammals
Gardner, D. S., Ozanne, S. E., & Sinclair, K. D. (2009) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2009.0121 · Cited by 75
“A key feature of compensatory growth is that rapid weight gain during childhood appears to partition energy disproportionately to abdominal adipose tissue (Wells 2007), which is thought to be causally linked to metabolic syndrome (Despres & Lemieux 2006).”
BackgroundWang, Y., Lin, S., Chuang, Y., Chen, C., Tung, K., & Sheu, W. H. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00301.2010 · Cited by 73
The relationship between body weight and inflammation: Lesson from anti-TNF-α antibody therapy
Peluso, I., & Palmery, M. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.10.008 · Cited by 76
Tada, A., & Miura, H. (2018) · BMC Oral Health · doi:10.1186/s12903-018-0525-3 · Cited by 80
“obesity is related to metabolic syndrome [49], further re-”
Lee, H., Ahn, J., Shin, S. S., & Yoon, M. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0212-0 · Cited by 72
Fecal microbiota transplantation in obesity metabolism: A meta analysis and systematic review
Zecheng, L., Donghai, L., Runchuan, G., Yuan, Q., Qi, J., Yijia, Z., Shuaman, R., Xiaoqi, L., Yi, W., Ni, M., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110803 · Cited by 69
Autoimmune responses and inflammation in type 2 diabetes
Prasad, M., Chen, E. W., Toh, S.-A. E. S., & Gascoigne, N. R. J. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0220-243r · Cited by 78
Harney, D. J., Cielesh, M., Chu, R., Cooke, K. C., James, D. E., Stöckli, J., & Larance, M. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108804 · Cited by 65
Visceral fat: A key mediator of NAFLD development and progression
Bansal, S., Vachher, M., Arora, T. K., Kumar, B., & Burman, A. (2023) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2023.200210 · Cited by 75
Giangregorio, F., Mosconi, E., Debellis, M. G., Provini, S., Esposito, C., Garolfi, M., Oraka, S., KALOUDI, O., Mustafazade, G., Marín‐Baselga, R., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195880 · Cited by 79
“This is closely linked to lipid metabolism disorders, such as obesity and hyperlipidemia [84,91] affects related metabolic processes, like purine/urate metabolism [10,92].”
BackgroundInfluentialLeunissen, R. W. J., Stijnen, T., & Hokken-Koelega, A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03320.x · Cited by 69
Wiklund, P., Xu, L., Lyytikäinen, A., Saltevo, J. T., Wang, Q., Völgyi, E., Munukka, E., Cheng, S., Alén, M., Keinanen-Kiukaanniemi, S. M., et al. (2011) · Public Health Nutrition · doi:10.1017/s1368980011002102 · Cited by 69
“Fortunately, postpartum lactation enables women to reverse this detrimental trend; during lactation, fat is mobilized primarily from the trunk and thighs((5)), reducing central fat accumulation, which is considered a major risk factor for metabolic disorders((6)).”
BackgroundFXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS
Maneschi, E., Vignozzi, L., Morelli, A., Mello, T., Filippi, S., Cellai, I., Comeglio, P., Sarchielli, E., Calcagno, A., Mazzanti, B., et al. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0109 · Cited by 68
“In addition to insulin resistance and visceral obesity, MetS is accompanied by dyslipidemia with high triglyceride levels and low HDL cholesterol concentrations and hypertension (Després & Lemieux 2006).”
BackgroundAnthropometric Measures of Obesity and Risk of Venous Thromboembolism: The Tromsø Study
Borch, K. H., Brækkan, S. K., Mathiesen, E. B., Njølstad, I., Wilsgaard, T., Störmer, J., & Hansen, J. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.188920 · Cited by 69
Adipose‐derived protein omentin prevents neointimal formation after arterial injury
Uemura, Y., Shibata, R., Kanemura, N., Ohashi, K., Kambara, T., Hiramatsu‐Ito, M., Enomoto, T., Yuasa, D., Joki, Y., Matsuo, K., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-258129 · Cited by 70
Intestinal removal of free fatty acids from hosts by Lactobacilli for the treatment of obesity
Chung, H., Yu, J. G., Lee, I., Liu, M., Shen, Y., Sharma, S. P., Jamal, M. A. H. M., Yoo, J., Kim, H., & Hong, S. (2016) · FEBS Open Bio · doi:10.1002/2211-5463.12024 · Cited by 65
Serum Fetuin-A Concentration and Endothelial Dysfunction in Chronic Kidney Disease
Çağlar, K., Yılmaz, M. İ., Sağlam, M., Çakır, E., Kılıç, S., Sönmez, A., Eyileten, T., Yenicesu, M., Oğuz, Y., Taşar, M., et al. (2008) · Nephron Clinical Practice · doi:10.1159/000120209 · Cited by 69
“These adipokines have been implicated in the metabolic syndrome [ 4 ], specifically the development of insulin resistance and hypertension.”
BackgroundMid-adulthood cardiometabolic risk factor profiles of sarcopenic obesity
Ma, J., Hwang, S., McMahon, G. M., Curhan, G. C., Mclean, R. R., Murabito, J. M., & Fox, C. S. (2016) · Obesity · doi:10.1002/oby.21356 · Cited by 68
“Both muscle and adipose tissue are actively involved in metabolic regulation (12,13).”
BackgroundScheen, A. J. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01681.x · Cited by 68
Obesity measures and risk of venous thromboembolism and myocardial infarction
Horvei, L. D., Brækkan, S. K., Mathiesen, E. B., Njølstad, I., Wilsgaard, T., & Hansen, J. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9950-z · Cited by 77
UFRGS-UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL
Saúde, B. D., & Pós-Graduação, P. R. D. (2009) · Cited by 68
Song, H., Shen, X., Deng, R., Zhang, Y., & Zheng, X. (2021) · Nutrition · doi:10.1016/j.nut.2021.111176 · Cited by 73
Gouveia, H. J. C. B., Urquiza-Martínez, M. V., Manhães‐de‐Castro, R., de Santana, B. J. R. C., Villarreal, J. P., Mercado-Camargo, R., Torner, L., Aquino, J. D. S., Toscano, A. E., & Guzmán‐Quevedo, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158344 · Cited by 74
“In fact, abdominal obesity is the main factor of the etS because it is associated with a complex neuroendocrine alteration [6].”
BackgroundEmploying machine learning for enhanced abdominal fat prediction in cavitation post-treatment
Hady, D. A. A., Mabrouk, O. M., & El‐Hafeez, T. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-60387-x · Cited by 68
Predicting waist circumference from body mass index
Bozeman, S. R., Hoaglin, D. C., Burton, T. M., Pashos, C. L., Ben-Joseph, R. H., & Hollenbeak, C. S. (2012) · BMC Medical Research Methodology · doi:10.1186/1471-2288-12-115 · Cited by 68
“In particular, increased visceral fat has been shown to be an important risk factor for cardiovascular disease and diabetes, among other metabolic disorders [4–6].”
BackgroundAssociation of Cholecystectomy with Metabolic Syndrome in a Chinese Population
Shen, C., Wu, X., Xu, C., Yu, C., Chen, P., & Li, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088189 · Cited by 71
“Obesity is the most important risk factor for metabolic syndrome, and a link between insulin resistance and metabolic syndrome has been established [10,11].”
BackgroundInflammation Theories in Psychotic Disorders: A Critical Review
Suvisaari, J., & Mantere, O. (2013) · Infectious Disorders - Drug Targets · doi:10.2174/18715265112129990032 · Cited by 66
“kines in people with visceral obesity [91], which most people with chronic psychotic disorders develop over time [83].”
Backgroundvan der Kooi, A.-L. L. F., Snijder, M. B., Peters, R. J. G., & van Valkengoed, I. G. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137739 · Cited by 75
“In addition to being insulin insensitive, excess visceral adipose tissue up-regulates the inflammatory response [31, 32] which may lead to catabolism and may consequently contribute to further decline in muscle mass and quality.”
BackgroundMamtani, M., Kulkarni, H. R., Dyer, T. D., Göring, H. H. H., Neary, J. L., Cole, S. A., Kent, J. W., Kumar, S., Glahn, D. C., Mahaney, M. C., et al. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0173-x · Cited by 69
“The rationale for using a combination of waist circumference and fasting triglyceride levels is to partially overcome the inability of waist circumference to discriminate between subcutaneous and visceral adiposity; raised serum triglycerides in the presence of increased waist circumference are more likely to indicate…”
BackgroundLi, H., Li, M., Liu, P., Wang, Y., Zhang, H., Li, H., Yang, S., Song, Y., Yin, Y., Gao, L., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07008 · Cited by 65
Fortner, R. T., Katzke, V. A., Kuhn, T. E., & Kaaks, R. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42542-9_3 · Cited by 85
Ruscica, M., Baragetti, A., Catapano, A. L., & Norata, G. D. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.12.005 · Cited by 69
Abnormal Myocardial Dietary Fatty Acid Metabolism and Diabetic Cardiomyopathy
Carpentier, A. C. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.029 · Cited by 71
Weight and weight change and risk of atrial fibrillation: the HUNT study
Feng, T., Malmo, V., Strand, L. B., Laugsand, L. E., Mørkedal, B., Aune, D., VATTEN, L. J., Ellekjær, H., Loennechen, J. P., Mukamal, K. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz390 · Cited by 70
Jiang, Y., Tan, S., Wang, Z., Guo, Z., Li, Q., & Wang, J. (2020) · Journal of Exercise Science & Fitness · doi:10.1016/j.jesf.2019.08.003 · Cited by 58
Sharma, S., Khare, P., Kumar, A., Chunduri, V., Kumar, A., Kapoor, P., Mangal, P., Kondepudi, K. K., Bishnoi, M., & Garg, M. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900999 · Cited by 73
Vassiloudis, I., Yiannakouris, N., Panagiotakos, D. B., Apostolopoulos, K., & Costarelli, V. (2014) · Journal of Nutrition Education and Behavior · doi:10.1016/j.jneb.2013.11.001 · Cited by 67
Blackburn, P., Lemieux, I., Alméras, N., Bergeron, J., Côté, M., Tremblay, A., Lamarche, B., & Després, J.-P. (2009) · Metabolism · doi:10.1016/j.metabol.2009.03.012 · Cited by 67
“However, controversy remains around the underlying pathophysiologic processes leading to the development of the metabolic syndrome (insulin resistance and/or hyperinsulinemia vs abdominal obesity) [5].”
BackgroundSelf-citationIdentifying pre-disease signals before metabolic syndrome in mice by dynamical network biomarkers
Koizumi, K., Oku, M., Hayashi, S., Inujima, A., Shibahara, N., Chen, L., Igarashi, Y., Tobe, K., Saito, S., Kadowaki, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45119-w · Cited by 67
Chen, D., Zhao, X., Sui, Z., Niu, H., Chen, L., Hu, C., Xuan, Q., Hou, X., Zhang, R., Zhou, L., et al. (2020) · Theranostics · doi:10.7150/thno.41106 · Cited by 78
“It will increase the risk of various diseases [3], especially type 2 diabetes (T2D) [4] and cardiovascular disease [5].”
BackgroundComposition, isolation, identification and function of adipose tissue-derived exosomes
Zhao, R., Zhao, T., He, Z., Cai, R., & Pang, W. (2021) · Adipocyte · doi:10.1080/21623945.2021.1983242 · Cited by 72
Kong, M. C., Xu, M., Zhou, Y., Geng, N., Lin, N., Song, W., Li, S., Piao, Y., Han, Z., Guo, R., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.871697 · Cited by 71
“Therefore, not all obese people develop diabetes and cardiovascular disease, and these diseases seem to be associated with visceral obesity even in lean people (28).”
BackgroundTargeting E3 ubiquitin ligases and their adaptors as a therapeutic strategy for metabolic diseases
Jeong, Y., Oh, A., Jung, Y. H., Gi, H., Kim, Y. U., & Kim, K. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01087-w · Cited by 68
“Metabolic diseases are heterogeneous diseases characterized by diverse dysregulated biological processes, including increased adiposity, insulin resistance, diabetes, hyperinsulinemia, hypertension, nonalcoholic fatty liver diseases (NAFLD), and dyslipidemia, which are related to accelerated atherosclerosis and cardio…”
BackgroundSugisawa, N., Tokunaga, M., Tanizawa, Y., Bando, E., Kawamura, T., & Terashima, M. (2011) · Gastric Cancer · doi:10.1007/s10120-011-0099-0 · Cited by 67
“Splenectomy is a well-known and widely accepted risk factor, because manipulation of the tail of the pancreas during the procedure increases the risk of pancreas-related infection [6, 14, 31].”
BackgroundRetinol‐binding Protein 4, Visceral Fat, and the Metabolic Syndrome: Effects of Weight Loss
Tschoner, A., Sturm, W., Engl, J., Kaser, S., Laimer, M., Laimer, E., Weiss, H., Patsch, J., & Ebenbichler, C. (2008) · Obesity · doi:10.1038/oby.2008.391 · Cited by 71
Prevention and Reversal of Obesity and Glucose Intolerance in Mice by DHA Derivatives
Rossmeisl, M., Jelenik, T., Jilkova, Z., Slamova, K., Kus, V., Hensler, M., Medrikova, D., Povysil, C., Flachs, P., Mohamed‐Ali, V., et al. (2009) · Obesity · doi:10.1038/oby.2008.602 · Cited by 66
““Dysfunctional” adipose tissue, which cannot properly handle the energy surplus resulting from a sedentary lifestyle combined with excessive calorie consumption, plays a central role in obesity-associated IR and type 2 diabetes (1).”
BackgroundMetabolic Syndrome and Cardiometabolic Risk Factors
Papakonstantinou, E., Lambadiari, V., Dimitriadis, G., & Zampelas, A. (2014) · Current Vascular Pharmacology · doi:10.2174/15701611113116660176 · Cited by 68
Zhang, P., Wang, R., Gao, C., Jiang, L., Lv, X., Song, Y., & Li, B. (2016) · PLOS ONE · doi:10.1371/journal.pone.0160402 · Cited by 64
“However, it can be further evaluated in terms of fat distribution via waist circumference (WC) and total cardiovascular risk factors [3, 4].”
BackgroundHypogonadism alters cecal and fecal microbiota in male mice
Harada, N., Hanaoka, R., Hanada, K., Izawa, T., Inui, H., & Yamaji, R. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1239680 · Cited by 69
“Obesity is strongly associated with an increased risk of cardiovascular disease.(17) Unlike in humans, dogs, cats, or pigs, androgen deprivation (e.”
BackgroundMoyer, B. J., Rojas, I. Y., Kerley-Hamilton, J. S., Nemani, K. V., Trask, H. W., Ringelberg, C. S., Gimi, B., Demidenko, E., & Tomlinson, C. R. (2017) · Nutrition Research · doi:10.1016/j.nutres.2017.06.002 · Cited by 70
Recent advances in the modification of taste and food preferences following bariatric surgery
Primeaux, S. D., de Silva, T., Tzeng, T. H., Chiang, M. C., & Hsia, D. S. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9365-0 · Cited by 66
“This is especially critical since excess visceral fat mass is associated with risk for glucose insensitivity and increased inflammation [46, 47].”
BackgroundMarrelli, M., Statti, G. A., & Conforti, F. (2020) · Molecules · doi:10.3390/molecules25030649 · Cited by 84
Post-traumatic knee osteoarthritis; the role of inflammation and hemarthrosis on disease progression
Evers, B. J., van den Bosch, M. H. J., Blom, A. B., van der Kraan, P. M., Koëter, S., & Thurlings, R. M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.973870 · Cited by 71
Modulation of immunity by the secreted phospholipase A2 family
Murakami, M., Sato, H., & Taketomi, Y. (2023) · Immunological Reviews · doi:10.1111/imr.13205 · Cited by 68
Effect of obesity on outcomes of free autologous breast reconstruction: A meta-analysis
Schaverien, M. V., & McCulley, S. J. (2014) · Microsurgery · doi:10.1002/micr.22244 · Cited by 70
Maternal visfatin concentration in normal pregnancy
Mazaki‐Tovi, S., Romero, R. J., Kusanovic, J. P., Vaisbuch, E., Erez, O., Than, N. G., Chaiworapongsa, T., Nhan‐Chang, C., Pacora, P., Gotsch, F., et al. (2008) · Journal of Perinatal Medicine · doi:10.1515/jpm.2009.054 · Cited by 74
Vatier, C., Hénégar, C., Ciangura, C., Poitou, C., Bouillot, J., Basdevant, A., & Oppert, J. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0619-y · Cited by 70
“This seems of importance for changes in trunk fat mass, as this compartment represented more than half of total fat mass at baseline and because of the well-known metabolic and cardiovascular consequences of abdominal fat [30].”
BackgroundMaternal protein intake during pregnancy and offspring overweight 20 y later
Maslova, E., Rytter, D., Bech, B. H., Henriksen, T. B., Rasmussen, M. A., Olsen, S. F., & Halldorsson, T. I. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.082222 · Cited by 71
“This result may be explained by the previously observed stronger association for biomarkers of inflammation, cholesterol, and glucose homeostasis with central rather than total adiposity (41, 42).”
Disruption of G Protein-Coupled Receptor 39 Impairs Insulin Secretion in Vivo
Tremblay, F., Richard, A.-M. T., Will, S., Syed, J., Stedman, N., Perreault, M., & Gimeno, R. E. (2009) · Endocrinology · doi:10.1210/en.2008-1251 · Cited by 67
Visceral adiposopathy: a vascular perspective
Farb, M. G., & Gokce, N. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0047 · Cited by 79
“While we have chosen to focus on ectopic visceral fat specifically for the purposes of this review, accumulation of fat in other ectopic regions such as muscle, kidney, heart and liver have also been linked to adverse cardiometabolic risk and reviewed thoroughly elsewhere [9, 15, 16, 18, 19].”
Impact of visceral obesity on outcomes of laparoscopic colorectal surgery: a meta‐analysis
Yang, T., Wei, M., He, Y., Deng, X., & Wang, Z. (2015) · ANZ Journal of Surgery · doi:10.1111/ans.13132 · Cited by 74
“VFA ≥100 cm(2) was based on the Japan Society for the study of obesity,(53) and VFA ≥130 cm(2) was used because this value has been previously proven to be associated with elevated cardiovascular risk and with a substantial deterioration of metabolic variables predictive of the metabolic syndrome.(34,54) Anyway, diffe…”
MethodMetabolic syndrome and lifestyle modification
Takahara, M., & Shimomura, I. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9294-8 · Cited by 70
“, the liver, the skeletal muscle, the pancreas, and the heart [88, 89].”
BackgroundTestosterone a key factor in gender related metabolic syndrome
Bianchi, V. E., & Locatelli, V. (2018) · Obesity Reviews · doi:10.1111/obr.12633 · Cited by 78
“The type of fat distribution determines large metabolic differences because only visceral fat is related to insulin resistance, glucose intolerance and MetS, (29,30) also to systemic inflammation in type-2-diabetes (31) than subcutaneous adipose tissue (32).”
BackgroundInfluentialKonieczna, J., Abete, I., Galmés, A. M., Babió, N., Colom, A., Zulet, M. Á., Estruch, R., Vidal, J., Toledo, E., Díaz‐López, A., et al. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.07.005 · Cited by 69
Song, H., Shen, X., Zhou, Y., & Zheng, X. (2021) · Food & Function · doi:10.1039/d1fo01394g · Cited by 68
Rare loss of function variants in the hepatokine gene INHBE protect from abdominal obesity
Deaton, A. M., Dubey, A., Ward, L. D., Dornbos, P., Flannick, J., AMP-T2D-GENES Consortium, Yee, E., Ticau, S., Noetzli, L., Parker, M. M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31757-8 · Cited by 57
Evans, J., Goedecke, J. H., Söderström, I., Burén, J., Alvehus, M., Blomquist, C., Jonsson, F., Hayes, P. M., Adams, K., Dave, J. A., et al. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03883.x · Cited by 71
Adipokines in the treatment of diabetes mellitus and obesity
Catalán, V., Gómez‐Ambrosi, J., Rodríguez, A., Salvador, J., & Frühbeck, G. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802618811 · Cited by 72
“It has been shown that approximately 20% of all genes in SAT and about 30% in VAT encode for adipokine secretion [80] .”
BackgroundInfluentialAntidepressants induce cellular insulin resistance by activation of IRS-1 kinases
Levkovitz, Y., Ben-shushan, G., Herschkovitz, A., Isaac, R., Gil‐Ad, I., Shvartsman, D. E., Ronen, D., Weizman, A., & Zick, Y. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.05.009 · Cited by 69
“Weight gain often leads to obesity which is associated with an increased incidence of insulin resistance, diabetes, hypertension, dyslipidemia and coronary artery disease (Despres and Lemieux, 2006).”
BackgroundRho-Kinase Inhibition Ameliorates Metabolic Disorders through Activation of AMPK Pathway in Mice
Noda, K., Nakajima, S., Godo, S., Saito, H., Ikeda, S., Shimizu, T., Enkhjargal, B., Fukumoto, Y., Tsukita, S., Yamada, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110446 · Cited by 67
“terized by visceral obesity, insulin resistance and initiation of several atherogenic signs, such as hypertension, glucose intolerance and hyperlipidemia [1].”
BackgroundKang, H., Shim, J., Lee, H. R., Park, B., Linton, J. A., & Lee, Y. (2014) · Journal of Epidemiology · doi:10.2188/jea.je20130017 · Cited by 66
Silveira, L. S., Monteiro, P. A., Antunes, B. M., Seraphim, P. M., Fernandes, R. A., Christófaro, D. G. D., & Júnior, I. F. F. (2013) · BMC Pediatrics · doi:10.1186/1471-2431-13-115 · Cited by 65
“; licensee BioMed Central Commons Attribution License (http://creativec reproduction in any medium, provided the or Deeper analysis have shown that, not only the total, but the distribution of excessive adipose tissue seems to determine the development of these comorbidities and, therefore, abdominal obesity (intra-ab…”
BackgroundResultInfluentialEquine Metabolic Syndrome: A Complex Disease Influenced by Genetics and the Environment
McCue, M. E., Geor, R. J., & Schultz, N. E. (2015) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2015.03.004 · Cited by 81
Metabolic syndrome in central Brazil: prevalence and correlates in the adult population
Dutra, E. S., de Carvalho, K. M. B., Miazaki, É. S., Hamann, E. M., & Ito, M. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-20 · Cited by 65
“The strong association between abdominal obesity and MetS is well-recognized [42,43].”
BackgroundKang, Y. M., Jung, C. H., Cho, Y. K., Jang, J. E., Hwang, J. Y., Kim, E. H., Lee, W. J., Park, J.-Y., & Kim, H.-K. (2017) · PLOS ONE · doi:10.1371/journal.pone.0179635 · Cited by 64
Elsaid, N. H., Sadik, N. A., Ramadan, N., Fayez, S. E., & Mohamed, N. (2018) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2018.05.003 · Cited by 68
Ghosh, D., Peng, J., Brown, K., Sirsi, S. R., Mineo, C., Shaul, P. W., & Hoyt, K. (2019) · Journal of Ultrasound in Medicine · doi:10.1002/jum.14956 · Cited by 66
“induced insulin resistance and type 2 diabetes.(3) Despite recognition that weight control measures are critically important to type 2 diabetes prevention and management, long-term results from lifestyle-directed or pharmacologic interventions are generally disappointing.”
BackgroundAcute and longer-term body composition changes after bariatric surgery
Maïmoun, L., Lefebvre, P., Aouinti, S., Picot, M.-C., Mariano-Goulart, D., & Nocca, D. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.07.006 · Cited by 63
Bourrie, B. C. T., Cotter, P. D., & Willing, B. P. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.04.039 · Cited by 64
Zhou, X., Zhang, J., Chen, Y., Ma, T., Wang, Y., Wang, J., & Zhang, Z. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132354 · Cited by 64
“Several large longitudinal population-based and mild cognitive impairment (MCI) [2–4].”
DeFilipp, Z. M., Duarte, R. F., Snowden, J. A., Majhail, N. S., Greenfield, D., López‐Miranda, J., Arat, M., Baker, K. S., Burns, L. J., Duncan, C., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.05.007 · Cited by 65
“Waist circumference, which emphasizes visceral adipose deposits, is preferentially used in the evaluation of abdominal obesity when defining MetS (see Table 1) as this distribution of fat accumulation independently confers cardiometabolic risk [29, 30].”
Managing cardiometabolic risk in primary care: summary of the 2011 consensus statement.
Chatterjee, A., Harris, S. B., Leiter, L. A., FITCHETT, D. H., Teoh, H., & Bhattacharyya, O. K. (2012) · Europe PMC (PubMed Central) · Cited by 96
Samouda, H., Dutour, A., Chaumoître, K., Panuel, M., Dutour, O., & Dadoun, F. (2013) · Obesity · doi:10.1002/oby.20033 · Cited by 69
“VAT is a very important and independent predictor, related to body composition, of cardiovascular diseases (1-5,29).”
BackgroundImpact of obesity on surgical and oncological outcomes in the management of colorectal cancer
Healy, L., Ryan, A. M., Sutton, E., Younger, K. M., Mehigan, B. J., Stephens, R., & Reynolds, J. V. (2010) · International Journal of Colorectal Disease · doi:10.1007/s00384-010-0963-0 · Cited by 64
“Visceral obesity independently increases cardiovascular risk [26] and diabetes and is associated with insulin resistance; therefore, visceral defined obesity may be a more sensitive indicator of underlying co-morbid medical conditions compared with BMI-defined obesity.”
BackgroundNormal-Weight Obesity: Implications for Cardiovascular Health
Jean, N., Somers, V. K., Sochor, O., Medina‐Inojosa, J. R., Llano, E. M., & López-Jiménez, F. A. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0464-7 · Cited by 69
Thomas, E. L., Collins, A. L., McCarthy, J. P., Fitzpatrick, J. A., Durighel, G., Goldstone, A. P., & Bell, J. D. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.18 · Cited by 64
“dtd"[ ]> Introduction Excess abdominal adiposity is known to predispose to diabetes and cardiovascular disease (”
Insulin resistance in the liver: Deficiency or excess of insulin?
Bazotte, R. B., Silva, L. G., & Schiavon, F. P. M. (2014) · Cell Cycle · doi:10.4161/15384101.2014.947750 · Cited by 75
“2, starting with an increased basal rate of lipolysis as a consequence of augmented visceral adiposity.(22,77) Because insulin stimulates expansion of visceral fat, this pathologic process functions as a self-sustaining closed-loop system that will only be interrupted by weight loss (diet and/or exercise) and /or use…”
BackgroundLactobacillus plantarum OLL2712 Regulates Glucose Metabolism in C57BL/6 Mice Fed a High-Fat Diet
SAKAI, T., TAKI, T., NAKAMOTO, A., SHUTO, E., TSUTSUMI, R., TOSHIMITSU, T., MAKINO, S., & IKEGAMI, S. (2013) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.59.144 · Cited by 64
Shen, R., Zhang, W., Dong, J., Ren, G., & Chen, M. (2014) · Food and Agricultural Immunology · doi:10.1080/09540105.2013.876976 · Cited by 69
Cameron, A. J. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.11.026 · Cited by 75
“(35) It might therefore be assumed that clinical definitions of the metabolic syndrome would identify an additional element of cardiometabolic risk.(36) This assumption, however, does not fully take into account the purpose of clinical definitions of the metabolic syndrome.”
BackgroundLi, S., Xiao, J., Ji, L., Weng, J., Jia, W., Lu, J., Zhou, Z., Guo, X., Liu, J., Shan, Z., et al. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.03.015 · Cited by 60
“Visceral fat is associated with increased circulating inflammatory cytokines and adhesion molecules[4, 5, 34–37], which promotes the development of insulin resistance and type 2 diabetes[4, 5, 34, 38].”
BackgroundCircadian Rhythms in Adipose Tissue Physiology
Kiehn, J., Tsang, A. H. K., Heyde, I., Leinweber, B., Kolbe, I., Leliavski, A., & Oster, H. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160017 · Cited by 73
Chen, Y., Wu, S., & Tian, Y. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.95 · Cited by 69
A miR-327–FGF10–FGFR2-mediated autocrine signaling mechanism controls white fat browning
Fischer, C., Seki, T., Lim, S., Nakamura, M., Andersson, P., Yang, Y., Honek, J., Wang, Y., Gao, Y., Fang, C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02158-z · Cited by 66
Metadata
- Authors
- Després, J.-P., & Lemieux, I.
- Venue
- Nature
- Published
- 2006-12-13
- Volume
- 444
- Issue
- 7121
- Pages
- 881-887
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1991334358
- Semantic Scholar
- 12903a24428f6c6024aed0c7b8de08306f8b15ff
- Cited by
- 4,354
- References
- 94
- Citations by year
- 2026: 146 · 2025: 172 · 2024: 216 · 2023: 209 · 2022: 259 · 2021: 259 · 2020: 223 · 2019: 231 · 2018: 236 · 2017: 225 · 2016: 265 · 2015: 236 · 2014: 270 · 2013: 269 · 2012: 241
- FWCI
- 21.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- abdominal obesity, metabolic syndrome, insulin resistance, diabetes risk, cardiovascular risk, inflammation, risk assessment algorithm, diagnostic criteria
- MeSH terms
- Abdomen, Cardiovascular Diseases, Humans, Obesity, Risk Assessment, Metabolic Syndrome, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.